Event Abstract

Biomimetic hydroxyapatite-containing PLLA/PCL electrospun nanofibrous scaffold for bone tissue engineering

  • 1 Northwestern Polytechnical University, Key Laboratory for Space Bioscience and Biotechnology, School of Life Sciences, China

Introduction: Bone defect is one of the most common diseases in clinical department of orthopedic. It is badly in need of synthetic materials for the repair and reconstruction of bone defect[1]. Recently electrospinning is widely used for fabricating nanoscale fibers for tissue engineering due to its various advantages such as simplicity of process, high specific surface areas, tunable porosity[4]. In this study, PCL and PLLA were used as the main component for the nanofibers[2].

Materials and Methods: PLLA (MW 200 kDa), PCL (MW 80 kDa), HAP, DCM, DMF, dexamethasone, L-ascorbic acid, β-sodium glycerophosphate, α-MEM, CCK-8, Alkaline Phosphatase Assay Kit, alizarin red S, Cetylpyridinium chloride, Mouse Osteocalcin ELISA Kit.

The scaffolds were obtained by electrospinning the mixed solution of PLLA/PCL/HAP[5]. The morphology of the scaffolds was investigated with SEM, while the diameter of the fibers, pore size were tested, respectively[6].

The in vitro bioactivity was assessed by CCK-8. The osteoblast mineralization were investigated the ALP activity and alizarin red S staining[3]. Osteocalcin (OCN) is another osteoblast marker that participate in controlling osteoblast function and bone extracellular matrix mineralization.

Results and Discussion: The morphology of the electrospun PLLA/PCL/HAP nanofibers was observed by SEM and the fiber diameters were showed by Figure 1. The pore size of the scaffold were 772.7±165.9 nm, 1167.2±168.9 nm, 1337.9±137.2 nm, respectively.

Pre-osteoblast MC3T3-E1 proliferation on scaffold was evaluated using CCK-8 test (Figure 2-left). ALP activity after MC3T3-E1 incubated on PLLA/PCL/HAP scaffold on 5, 7, and 9 days was showed in Figure 2-right.

Figure 3-left shows the results of AR-S staining for the three groups after 27 days of culturing with MC3T3-E1. The secretion levels of osteocalcin of different osteogenic culture time were showed in Figure 3-right.

Conclusions: We designed PLLA/PCL nanofibrous scaffold containing HAP by electrospinning. Based on our experimental data, the composite scaffolds, PLLA/PCL/HAP especially, showed admirable bioactivity and promoted proliferation and osteogenic differentiation of MC3T3-E1 cells.

References:
[1] Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration
[2] Comparison of osteogenic differentiation potential of human adult stem cells loaded on bioceramic-coated electrospun poly (L-lactide) nanofibres
[3] Biocompatibility and degradation characteristics of PLGA-based electrospun nanofibrous scaffolds with nanoapatite incorporation
[4] Electrospun poly(L-lactic acid)/hydroxyapatite composite fibrous scaffolds for bone tissue engineering
[5] Electrospun polyurethane/hydroxyapatite bioactive scaffolds for bone tissue engineering: the role of solvent and hydroxyapatite particles
[6] Electrospun polyurethane/hydroxyapatite bioactive scaffolds for bone tissue engineering: the role of solvent and hydroxyapatite particles

Keywords: Tissue Engineering, nanofiber, 3D scaffold, biodegredation

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: General Session Oral

Topic: Synthetic scaffolds as extracellular matrices

Citation: Qi H and Lu T (2016). Biomimetic hydroxyapatite-containing PLLA/PCL electrospun nanofibrous scaffold for bone tissue engineering. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.02211

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.